Friday, January 06, 2023 2:33:32 PM
Yes, there were Buyout talks with other Co's a couple of years ago, but they were just preliminary meetings to see what RGBP was all about, nothing more! If I'm not mistaken, one or maybe 2 Co's told RGBP that we had to meet certain requirements before they would meet again? It's only natural to see Co's wanting to see concrete steps being taken, where it would help them to gain revenues sooner than later!
Also, like Insurance Co's, there probably were a few LOW bids, but were too low, as Koos thought that there was too much potential to be low-balled, and refused? Evidently Koos has somewhat of a treasure chest to pay the bills, something few Investors have! But all in All, there doesn't seem anything to stop the progress, which can only be slow? But when PRs start coming in, they will be VERY GOOD ONES, as the developmental issues are long gone! We should hear news about Clinical trials for at least ONE pharmaceutical agent, maybe 2, as a few seem to enter the trials close after one another a year or two ago! But close may mean years instead of Months, I don't know, and clearing trial 1 may only mean that the next Clinical trial (2 or 3) is soon to be launched if the money is there? Maybe a trial may be in stage 2, and that is quite possible?
As I mentioned before, I bought into NASTECH PHARMACEUTICALS INC. a number of years ago, and at $.18 cents a share! But Bad Luck hit me as I had substantial bills to pay and had to sell-out! I forgot about it due to severe circumstances, but one day a few years later, I had the guts to look at NASD, I think the symbol was, and I was disheartened because the stock rose to $ 23+ Dollars a share! Yes, 23+ Bucks a share!! That's the way it is in this Penny sector! The best to all, and a healthy 2023!! T.
Recent HYSR News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/03/2024 08:06:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:05:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/21/2024 07:32:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 09:01:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2024 05:15:09 AM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 01/25/2024 09:40:59 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/24/2024 09:32:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2023 09:03:04 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:33:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:13:34 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM